Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
These medications are approved by the Food and Drug Administration (FDA) and are typically prescribed to patients with either a BMI greater than 30 kg/m 2 (obese) or a BMI greater than 27 kg/m 2 with a weight-related comorbidity as adjuncts to lifestyle modifications
Participants who had not lost at least 5% of their starting body weight by week 12 rarely achieved robust results by week 48
Its clinical trial (STEP 1) showed an average weight loss of 14.9% and up to 20.7% with the newly approved 7.2mg dose (STEP UP, Lancet 2025)
2.5 mg, 5 mg, 10 mg) Designed for self-use with minimal pain No need to mix or primejust inject once a week
US$ 23.84
US$ 29.59
US$ 26.46
US$ 26.27
